Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Imaging of Nicotinic Acetylcholine Receptors in Tobacco Users and Nonusers
NCT04055467Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Dec 2019
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [18F]ASEM in Tobacco Use Disorder (TUD), sponsored by Johns Hopkins University. Primary endpoints: Distribution Volume at 1 day, Minnesota Nicotine Withdrawal Scale at 1 day and 1 more. Started Dec 2019; status: completed.
02
Drugs
[18F]ASEM
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT04055467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04055467.